Search for: "Cooperative Communications, Inc. v. AT & T CORP." Results 121 - 140 of 182
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jun 2008, 6:49 am
: (Class 46), Managing Intellectual Property guide to trade mark blogs: (Managing Intellectual Property), gTLD expansion ahead: (Managing Intellectual Property), Interview with Hugo Boss general counsel regarding brand protection: (Managing Intellectual Property), When IP rights collide – trade mark rights just one piece of larger IP puzzle when securing brand protection: (Managing Intellectual Property), Iron man: Marvel morphs into a movie studio – Film financing and brand… [read post]
11 Nov 2020, 4:14 pm by Bona Law PC
Dep’t of Justice, Criminal Div., Evaluation of Corporate Compliance Programs (June 2020); DOJ updated Justice Manual. [read post]
25 Dec 2011, 11:54 am by admin
See also: National Post – Supreme Court Won’t Hear U.S. [read post]
27 Dec 2014, 2:19 am by Ben
Bradley Cooper who pushed the button? [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
19 Sep 2008, 6:00 pm
: (Ars Technica), Google, GE join forces for green tech research, lobbying: (Ars Technica), AIPPI Congress: how to protect you IP rights in virtual worlds (Managing Intellectual Property), Industry still wary of ICANN plan for new top-level internet domains: (Intellectual Property Watch), Ubuntu-Firefox EULA dustup reignites OSS licensing debate: (Ars Technica), Media standard backers attempt Apple-less solo run: (Out-Law), Open Source in Mobile conference: OpenMoko CEO says embrace fragmentation,… [read post]
23 May 2008, 1:03 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Indian Patent Office decisions now searchable and downloadable: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), Institute for Progress study on inter partes re-examination: (Peter Zura's 271 Patent Blog), (IAM), (Hal Wegner) Nintendo loses patent suit over 3D controller; Anascape awarded $21M in damages: motion for… [read post]
23 Oct 2009, 10:00 am
The Legal Aid Society; Real Estate Board of New York; New York State Tenants & Neighbors Coalition, Inc. et al.; Community Housing Improvement Program of New York Inc. et al.; Maria del Carmen Arroyo et al.; Rent Stabilization Association of New York City, Inc.; Office of Manhattan Borough President; Urban Justice Center; Mitchell-Lama Residents Coalition, amici curiae. [read post]
12 May 2009, 12:20 pm
The goal of these efforts was to clarify the analytical framework for assessing the legality of single-firm conduct and to provide guidance to the courts, antitrust counselors, and the business community. [read post]